echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > How to treat rigidity effectively?

    How to treat rigidity effectively?

    • Last Update: 2021-09-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Ankylosing spondylitis is a disease with inflammation of the sacroiliac joints and attachment points as the main symptoms.


    The main manifestations of ankylosing spondylitis include low back pain, morning stiffness, pain at the muscle attachment point, chest pain, and chest hunch, after sitting for a long time, thigh pain, hip pain, and foot pain.


    In addition to the bone destruction caused by the spine cones, the fibrosis and ossification of the ligaments around the cones, and the formation of new bones formed by the anterior and posterior ligaments of the cones are called osteophytes, which ultimately cause the entire spine to become bamboo-like ankylosis.


    Treatment principles

    Patients must first realize that there is no cure for rigidity.


    The treatment follows the principle: through comprehensive treatment such as non-drugs, drugs and surgery , to relieve pain and stiffness, control or reduce inflammation, maintain a good posture, prevent spine or joint deformation, and correct deformed joints when necessary to improve and improve the quality of life of patients Purpose


    Principle 1: Non-drug treatment

    Non-drug treatment mainly includes the following aspects:

    1.


    2.


    3.


    4.


    5.


    Principle 2: Medication

    Drug therapy mainly includes non-steroidal anti-inflammatory drugs, biological agents, and other drugs


    01Non -steroidal anti-inflammatory drugs

    Non-steroidal anti-inflammatory drugs, as the first choice for symptomatic treatment of patients with either early or late stages of rigidity, can quickly improve the patients' back pain and morning stiffness, reduce joint swelling and pain, and increase the range of motion


    The main adverse reaction of non-steroidal anti-inflammatory drugs is gastrointestinal discomfort, a few can cause peptic ulcer; other less common cardiovascular diseases such as hypertension


    02 biological agents

    Biological agents include: Yisaipu, adalimumab, infliximab, etanercept and so on


    After treatment with non-steroidal anti-inflammatory drugs, glucocorticoids, sulfasalazine, etc.


    However, before treatment with biological agents, it is necessary to assess whether patients with AS have a history of tuberculosis and hepatitis.


    03 other drugs

    Glucocorticoids: For refractory peripheral arthritis (such as knee joint) effusions that are not effective in systemic medication, intra-articular injection of glucocorticoids can be used for treatment.
    Also for patients with intractable sacroiliac joint pain, CT-guided treatment can be selected Glucocorticoids are injected into the sacroiliac joints, and short-term oral small-dose (less than 10mg) hormone therapy can be given when the eye is affected and iritis occurs
    .

    Sulfasalazine: It can improve the pain, swelling and stiffness of ankylosing joints, and can reduce laboratory activity indexes (hypersensitivity C-reactive protein, erythrocyte sedimentation rate).
    It is especially suitable for improving peripheral arthritis in patients with rigidity
    .

    Thalidomide: some patients with refractory AS or patients with recurrent oral ulcers can be used
    .

    Anti-rheumatic drugs such as methotrexate: For patients with peripheral joint involvement, they can be used as appropriate
    .

    Principle 3: Surgical treatment

    Severe spinal kyphosis patients can undergo corrective surgery after the condition is stabilized, and lumbar deformities can be corrected by spinal osteotomy
    .

    However, surgical treatment is not once and for all
    .
    Hip replacement surgery may have various complications, and the cost is high, and more than 20% of the surgical patients require a second revision
    .

    Therefore, for ankylosing spondylitis hip joint disease, patients should pay more attention to early treatment to avoid disability
    .

    Ankylosing spondylitis is a disease with inflammation of the sacroiliac joints and attachment points as the main symptoms.
    The etiology of this disease is not clear.
    It is an autoimmune system disease with the spine as the main lesion
    .

    The main manifestations of ankylosing spondylitis include low back pain, morning stiffness, pain at the muscle attachment point, chest pain, and chest hunch, after sitting for a long time, thigh pain, hip pain, and foot pain.
    In addition, it is difficult to turn over at night and a sense of stiffness in the morning as prominent clinical manifestations
    .

    Difficulty turning over at night and stiffness in the morning are prominent clinical manifestations
    .
    Difficulty turning over at night and stiffness in the morning are prominent clinical manifestations
    .

    In addition to the bone destruction caused by the spine cones, the fibrosis and ossification of the ligaments around the cones, and the formation of new bones formed by the anterior and posterior ligaments of the cones are called osteophytes, which ultimately cause the entire spine to become bamboo-like ankylosis.
    The loss of the normal physiological curvature of the entire spine seriously affects normal work and life
    .

    Treatment principles

    Patients must first realize that there is no cure for rigidity.
    If patients can be diagnosed and treated in a timely manner, they can control their symptoms and improve their prognosis
    .

    The treatment follows the principle: through comprehensive treatment such as non-drugs, drugs and surgery , to relieve pain and stiffness, control or reduce inflammation, maintain a good posture, prevent spine or joint deformation, and correct deformed joints when necessary to improve and improve the quality of life of patients Purpose
    .

    Through the comprehensive treatment of non-drugs, drugs, and surgery.
    Through the comprehensive treatment of non-drugs, drugs and surgery.
    Principle 1: Non-drug treatment

    Non-drug treatment mainly includes the following aspects:

    1.
    Doctors propagate disease knowledge to patients and their families, which helps patients actively participate in and cooperate with doctors in treatment;

    Take the initiative

    2.
    Appropriately adhere to reasonable physical exercises, strengthen the muscles of the spine and increase lung capacity, swimming is a better way of exercise;

    Swimming is a better way to exercise; swimming is a better way to exercise;

    3.
    When standing, try to keep your chest straight, tuck your abdomen in, and look straight ahead to avoid flexion deformity;

    Keep your chest, abdomen, and eyes straight ahead, keep your chest, abdomen, and eyes straight ahead,

    4.
    Smokers quit smoking, smoking is a bad factor for functional prognosis;

    Smoking is a bad factor for functional prognosis ; smoking is a bad factor for functional prognosis;

    5.
    Provide necessary physical therapy for painful and inflammatory joints or soft tissues, such as external application, fumigation, acupuncture and other treatments
    .

    Such as external application, fumigation, acupuncture and other treatments
    .
    Such as external application, fumigation, acupuncture and other treatments
    .

    Principle 2: Medication Principle 2: Principle 2:

    Drug therapy mainly includes non-steroidal anti-inflammatory drugs, biological agents, and other drugs
    .

    01Non -steroidal anti-inflammatory drugs

    Non-steroidal anti-inflammatory drugs, as the first choice for symptomatic treatment of patients with either early or late stages of rigidity, can quickly improve the patients' back pain and morning stiffness, reduce joint swelling and pain, and increase the range of motion
    .
    There are many kinds of them, and their effects on rigidity are roughly the same
    .

    Non-steroidal anti-inflammatory drugs are the first choice for symptomatic treatment of patients with early or late stage rigidity, and non-steroidal anti-inflammatory drugs are the first choice for symptomatic treatment of patients with early or late stage rigidity.

    The main adverse reaction of non-steroidal anti-inflammatory drugs is gastrointestinal discomfort, a few can cause peptic ulcer; other less common cardiovascular diseases such as hypertension
    .
    Rheumatologists will select a non-steroidal anti-inflammatory drug according to the specific situation of each patient, and monitor the adverse drug reactions during the medication process and make timely adjustments
    .

    02 biological agents

    02 biological agents

    Biological agents include: Yisaipu, adalimumab, infliximab, etanercept and so on
    .

    After treatment with non-steroidal anti-inflammatory drugs, glucocorticoids, sulfasalazine, etc.
    , there is still moderate to severe active spinal disease (spine stiffness and straightening, bamboo joint changes, etc.
    ) or moderate to severe activity Peripheral arthritis (heel, knee joint, etc.
    ) may be treated with biological agents
    .

    Consider using biologics for treatment.
    Consider using biologics for treatment.

    However, before treatment with biological agents, it is necessary to assess whether patients with AS have a history of tuberculosis and hepatitis.
    After tuberculosis and hepatitis are ruled out, biological agents can be used for treatment
    .

    03 other drugs

    Glucocorticoids: For refractory peripheral arthritis (such as knee joint) effusions that are not effective in systemic medication, intra-articular injection of glucocorticoids can be used for treatment.
    Also for patients with intractable sacroiliac joint pain, CT-guided treatment can be selected Glucocorticoids are injected into the sacroiliac joints, and short-term oral small-dose (less than 10mg) hormone therapy can be given when the eye is affected and iritis occurs
    .

    Glucocorticoids: Glucocorticoids:

    Sulfasalazine: It can improve the pain, swelling and stiffness of ankylosing joints, and can reduce laboratory activity indexes (hypersensitivity C-reactive protein, erythrocyte sedimentation rate).
    It is especially suitable for improving peripheral arthritis in patients with rigidity
    .

    Sulfasalazine: Sulfasalazine:

    Thalidomide: some patients with refractory AS or patients with recurrent oral ulcers can be used
    .

    Thalidomide: Thalidomide:

    Anti-rheumatic drugs such as methotrexate: For patients with peripheral joint involvement, they can be used as appropriate
    .

    Antirheumatic drugs such as methotrexate : Antirheumatic drugs such as methotrexate:

    Principle 3: Surgical treatment Principle 3: Principle 3:

    Severe spinal kyphosis patients can undergo corrective surgery after the condition is stabilized, and lumbar deformities can be corrected by spinal osteotomy
    .

    However, surgical treatment is not once and for all
    .
    Hip replacement surgery may have various complications, and the cost is high, and more than 20% of the surgical patients require a second revision
    .

    Surgical treatment is not once and for all Surgical treatment is not once and for all

    Therefore, for ankylosing spondylitis hip joint disease, patients should pay more attention to early treatment to avoid disability
    .



    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.